Navigation Links
Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
Date:11/2/2009

. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the acute treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials, and is projecting a New Drug Application submission in early 2010.

Alexza has completed an end-of-Phase 2 meeting with the FDA for AZ-001 (Staccato prochlorperazine) and has completed two Phase 2 studies with AZ-104 (Staccato loxapine, low-dose). Both product candidates are being developed for the acute treatment of migraine headache.

AZ-002 (Staccato alprazolam) has completed Phase 1 testing and one Phase 2a proof-of-concept clinical trial. Product candidates that have completed Phase 1 testing are AZ-003 (Staccato fentanyl) for the treatment of breakthrough pain, and AZ-007 (Staccato zaleplon) for the treatment of insomnia. More information, including this and past press releases from Alexza, is available online at www.alexza.com.

Safe Harbor Statement

The anticipated news release and conference call will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs. The Company's forward-looking statements also involve assumptions that, if they prove incorrect, would cause its results to differ material
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015  Check-Cap Ltd. (NASDAQ: CHEK ), ... development of a preparation-free ingestible imaging capsule that utilizes ... today that its CEO, Guy Neev , will ring ... day.  Neev and Check-Cap will participate in the closing ... public offering and simultaneous private placement which raised a ...
(Date:3/30/2015)... 2015 Perrigo Company plc (NYSE: PRGO ... Healthcare Products®," today announced that it has completed the ... a cash and equity transaction valued at approximately €3.8 ... debt. Sellers are Marc Coucke , Waterland Private ...   "The combination of Perrigo and ...
(Date:3/30/2015)... BOSTON , March 30, 2015  MedAptus® ... newest solution designed to simplify pre-care needs for ... rules-based intelligence to automatically assign patients to hospitalists ... continuity of care and other requirements such as ... efficiency. ...
Breaking Medicine Technology:Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 2Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 3Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 4Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company 5MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3
... LOVELAND, Colo., May 16, 2012   Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products, today announced it ... Co. Investor Conference on Wednesday, May 23, 2012 at the ... D in Santa Monica, California.  The presentation is scheduled to ...
... SOUTH SAN FRANCISCO, Calif., May 16, 2012  Rigel Pharmaceuticals, ... respiratory franchise by focusing on two innovative, comprehensive treatment ... R343, an inhaled SYK inhibitor, will be entering a ... to moderate asthmatic patients. The other, R256, an inhaled ...
Cached Medicine Technology:Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 2Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 3Rigel Advances Asthma Programs: Two Inhaled Drug Candidates Take Aim at Acute and Chronic Lung Disease 4
(Date:3/30/2015)... Follow us on LinkedIn ... and establish chronic pain rehabilitation centers are driving demand ... is poised to benefit from the rise in acute ... in chronic health conditions such as Cancer, degenerative diseases, ... While conventional treatment for pain management is dominated by ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 On March ... Ford Field, home of the Detroit Lions, LiveToBeSober.org hosted ... nationally recognized pastors, ministers and bishops as well as ... addressed the audience at the luncheon, including retired Detroit ... sponsor Per Wickstrom and two survivors of their own ...
(Date:3/30/2015)... Dr. Daniel Shapiro, one of the t ... on Phoenix’s Channel 12 News about the benefits of his ... alternative to facelifts developed by Dr. Shapiro. , Over the ... Aesthetic Plastic Surgery and Skin Klinic worked closely with 12 ... on GenXLift. The story detailed the experience and results of ...
(Date:3/30/2015)... CA (PRWEB) March 30, 2015 On ... blue polo for yellow to inspire courage in Seth ... from Severe Combined Immunodeficiency (SCID). SCID causes affected individuals ... marrow transplant is needed to allow the development of ... transplant last Friday, created a video with his family ...
(Date:3/30/2015)... 2015 DMG Productions announces the upcoming ... broadcast on Monday, April 20, 2015 at 7:30 a.m. ... , In this episode Innovations will explore Limbkeepers® non ... fragile, thinning skin on arms, hands, and legs from ... on how their products help reduce injuries, allow for ...
Breaking Medicine News(10 mins):Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Technological Developments, Better Patient Awareness & Affordability Drive the Pain Management Devices Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:LiveToBeSober.org Releases Highlight Reel of Substance Abuse Conference Keynote Speakers 2Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:New Episode of Innovations Airing Monday, April 20, 2015 Via Discovery Channel 2
... (HealthDay News) -- Personal independence and freedom are more important ... Researchers at the Victoria University of Wellington in New Zealand ... of more than 420,000 people from 63 countries and spanned ... autonomy, but it does not add to well-being or happiness." ...
... Where you get your news could play a significant ... strategy for addressing childhood obesity. According to a study ... of Public Health, whether you believe the keys to ... behavior changes or system-level factors such as marketing and ...
... from the United Kingdom cured well-established prostate tumors in ... effects. This novel cancer treatment approach encourages the immune ... from toxic chemotherapies and radiation treatments. Such a treatment ... free with fewer side effects than those experienced from ...
... -- Whether they are riding with an adult or just ... a running lawn mower, a doctor warns. "Kids should ... the age of 16 should not be allowed to operate ... Harris, pediatric podiatrist with the Loyola University Health System, said ...
... , FRIDAY, June 17 (HealthDay News) -- Last year, ... all U.S. counties, a new study shows. This trend, ... moving away, as well as decreases in fertility levels. Researchers ... (UNH) also found that rural areas are particularly hard hit ...
... LOUISVILLE, Ky. The first three patients to undergo ... involves the patient,s own stem cells continue to do ... the principal investigator. The "TGI-PVG IDE" clinical trial ... cells to line man-made bypass grafts to better the ...
Cached Medicine News:Health News:Freedom More Important to Happiness Than Wealth, Study Finds 2Health News:News source may steer perceived solution to childhood obesity 2Health News:News source may steer perceived solution to childhood obesity 3Health News:Mayo Clinic researchers use human vaccine to cure prostate cancer in mice 2Health News:Adults Reminded to Keep Kids Away From Lawn Mowers 2Health News:Deaths Exceed Births in 24% of U.S. Communities: Report 2Health News:University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care 2Health News:University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care 3Health News:University of Louisville surgeons perform first prosthetic bypass graft with patient's stem cells at point-of-care 4
... OMNI~NEB delivers breakthrough continuous low-flow nebulizer ... precise nozzle technology allows for optimal ... or without Heliox). OMNI~NEB takes on ... both routine and critical care situations. ...
... a spill-proof design and effective output, even ... All medical nebulizers are free-standing for easy ... are available., ,All Portex® medication nebulizer ... nebulizers feature consistently fine misting and the ...
... Eliminate the need for makeshift, modified nebulizer ... waste time gathering parts when your patient ... to deliver the utmost in Heliox rescue ... is fast becoming the standard of care ...
... Graham-Field has been developing diverse ... 58 years. Our medical-surgical products ... for innovation, quality and customer ... include the Labtron® line of ...
Medicine Products: